Belluscura has developed the X-PLOR, a lightweight, portable oxygen delivery device aimed at treating the millions of people globally suffering from chronic lung diseases. The company plans to launch this novel and cost-effective device in the US in 2019, with Europe to follow.
|Tekcapital investee Belluscura eyes raising GBP17.5 million in AIM IPO
|Intention to float - AIM
London Stock Exchange
|Medical device firm Belluscura has revealed plans for a London float
|Belluscur plans London float
|Acquisition for medical device company
Manufacture of consumer electronics
|Date||Amount||No. of Investors|
|Increase in Cash||£331.94k||£-376.28k|
Financial data drawn from last filed accounts don't necessarily reflect current trading activity.
|DYER, Anthony Stephen||Secretary||17/11/2017||British|
|DYER, Anthony Stephen||Director||17/11/2017||British|
|PIPER, Richard John||Director||21/05/2021||British|
|POUTNEY, David John||Director||21/05/2021||British|